Earnings Preview: LEGN to Report Financial Results Pre-market on May 13
U.S. Treasury Secretary and USTR to Meet With Chinese Counterparts Amid Possible Break in Trade War
Express News | U.S.-listed Chinese stocks surge at the opening, with Alibaba up over 4%.
Express News | U.S.-listed Chinese stocks surge in overnight trading, with Alibaba up over 4%.
What Does the Market Think About Legend Biotech?
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
RBC Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $84
Legend Biotech Price Target Maintained With a $84.00/Share by RBC Capital
RBC Capital Remains a Buy on Legend Biotech (LEGN)
Barclays Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $94
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Legend Biotech (LEGN)
Chinese concept stocks returning to the home market receive attention again: which companies have not yet returned and what is the scale of Holdings in US investment?
① How large is the scale of USA investors holding Chinese concept stocks? ② Which Chinese concept stock companies have not yet returned?
Legend Biotech Corporation (NASDAQ:LEGN) Investors Are Less Pessimistic Than Expected
Legend Biotech (LEGN) Gets a Buy From Barclays
Top Gap Ups and Downs on Tuesday: BAC, MUFG, SAN and More
U.S. stocks movement | Legend Biotech (LEGN.US) rises nearly 6%, focusing on the development of new cell therapies.
On Tuesday, Legend Biotech (LEGN.US) rose nearly 6%, closing at $34.02.
Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday
Demonstrating resilience under Trump's tariff threats, Johnson & Johnson (JNJ.US) raises its full-year revenue guidance.
Johnson & Johnson announced its financial results for the first quarter.
Express News | Legend Biotech Corp -Carvykti Generated About $369 Mln in Net Trade Sales During Quarter Ended March 31, 2025
J&J Kicks off Pharma Earnings Season With Guidance Raise Amid Looming Tariffs